Business Context and Reporting Period
This Form 8-K filing by CareDx, Inc. (CDNA) reports on the results of the 2022 Annual Meeting of Stockholders held on June 15, 2022. The record date for the meeting was April 20, 2022.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A quorum was established with 50,394,567 shares represented, constituting 94.7% of the 53,219,545 outstanding shares. Stockholders voted on three proposals:
- Proposal 1 (Election of Directors): Three Class II directors were elected to serve until the 2025 annual meeting.
- Fred E. Cohen, M.D., D. Phil: 28,232,211 votes For; 18,192,660 votes Withheld.
- Christine M. Cournoyer: 29,447,303 votes For; 16,977,568 votes Withheld.
- William A. Hagstrom: 29,399,555 votes For; 17,025,316 votes Withheld.
- Proposal 2 (Ratification of Auditors): Deloitte & Touche LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2022.
- Votes For: 50,357,847
- Votes Against: 21,910
- Abstentions: 14,810
- Proposal 3 (Executive Compensation): Advisory approval of named executive officer compensation.
- Votes For: 44,699,515
- Votes Against: 1,700,604
- Abstentions: 24,752
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the definitive proxy statement filed on May 2, 2022, for detailed biographies of the elected directors and compensation specifics.
- Confirm the high level of shareholder participation (94.7%) and the significant number of votes withheld for the election of Fred E. Cohen, M.D., D. Phil.
- Review the upcoming 10-K or 10-Q filings for the financial metrics absent from this 8-K.